Drive innovation with more predictable results.

We have more information than ever before about multiple sclerosis, Parkinson's disease, stroke, Alzheimer’s disease, and other neurological disorders. IQVIA helps you drill down and turn data into indication-specific insights.

Contact Us
Globally … neurological disorders were the leading cause of disability-adjusted life years and second leading cause of deaths.

2019 May;18(5):459-480

Innovate at the speed of analytics

As the leader in Human Data Science, IQVIA is at the forefront of integrating human science expertise with advances in analytics and technology to help those studying the brain ask smarter questions to get to better answers, faster. Like using the right data and algorithms to identify Alzheimer’s patients in early stages. 
IQVIA? CORE, a seamless, dynamic, and constant integration of IQVIA's capabilities that powers solutions and ideas.
IQVIA? CORE, a seamless, dynamic, and constant integration of IQVIA's capabilities that powers solutions and ideas.

Break through CNS challenges with the IQVIA CORE?

As one of the highest areas of unmet needs, central nervous system (CNS) diseases are diverse, occurring at different life stages and different severities. With fewer early stage trials and a high attrition rate, CNS development presents a higher level of risk. By integrating unparalleled data, advanced analytics and fit-for-purpose machine learning, IQVIA provides innovative approaches to help you manage risk and find the right path to success.

From research through commercialization, it's all powered by the IQVIA CORE, a holistic approach that integrates our resources to meet your needs.


Related Solutions
Real World Evidence

IQVIA is using vast quantities of data in powerful new ways. See how we can help you tap into information from past trials, patient reported outcomes and other sources to accelerate your research.

Research & Development

Explore our end-to-end, full service clinical development capabilities including Therapeutics expertise, Development Planning, Phase I early clinical development, Phase IIb/III and Phase IV Trials, Regulatory Submission and Post-Launch Studies.

Evidence Networks

Tap into evidence networks in oncology, neurology, immunology, and other therapy areas to enrich your studies.

Contact Us
Contact Us
Contact Us

Email Us

Get in touch today to discover the right solutions for you.

Call Us

We are pleased to speak with you during our standard business hours.

U.S. Toll-Free only
+1 866 267 4479

For international call please find a number in our toll-free list.